Cargando…
EBV-Mir-BART5-5p targets p53 independent pathway in cytoplasm: Potential role in EBV lymphomagenesis
Autores principales: | Wang, Wei-Ting, Guo, Jing-Ran, Wang, Li, Wu, Jia-Zhu, Shen, Hao-Rui, Kong, Yi-Lin, Xia, Yi, Li, Jian-Yong, Liang, Jin-Hua, Xu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311012/ https://www.ncbi.nlm.nih.gov/pubmed/37397514 http://dx.doi.org/10.1016/j.gendis.2022.07.003 |
Ejemplares similares
-
EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023) -
Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma
por: Wu, Zhen, et al.
Publicado: (2022) -
Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma
por: Cai, Longmei, et al.
Publicado: (2015) -
EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis
por: Ma, J, et al.
Publicado: (2016) -
Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis
por: Ghosh Roy, Shatadru, et al.
Publicado: (2016)